These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30604640)

  • 21. Intermittent injection vs patient-controlled analgesia for sickle cell crisis pain. Comparison in patients in the emergency department.
    Gonzalez ER; Bahal N; Hansen LA; Ware D; Bull DS; Ornato JP; Lehman ME
    Arch Intern Med; 1991 Jul; 151(7):1373-8. PubMed ID: 2064488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
    Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
    Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral morphine protocol for sickle cell crisis pain.
    Conti C; Tso E; Browne B
    Md Med J; 1996 Jan; 45(1):33-5. PubMed ID: 8569458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arterialization of venous blood for differentiation of sickle cell subjects in vaso-occlusive crisis.
    Nahavandi M; Tavakkoli F; Wyche MQ; Perlin E; Millis RM
    Hematology; 2003 Dec; 8(6):421-8. PubMed ID: 14668039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Red blood cell transfusions during sickle cell anemia vaso-occlusive crises: a report from the magnesium in crisis (MAGiC) study.
    Hulbert ML; Panepinto JA; Scott JP; Liem RI; Cook LJ; Simmons T; Brousseau DC;
    Transfusion; 2017 Aug; 57(8):1891-1897. PubMed ID: 28500682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pilot study of human recombinant hyaluronidase-enhanced subcutaneous hydration and opioid administration for sickle cell disease acute pain episodes.
    Sandoval M; Coleman P; Govani R; Siddiqui S; Todd KH
    J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):10-8. PubMed ID: 23527666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study.
    Nottage KA; Hankins JS; Faughnan LG; James DM; Richardson J; Christensen R; Kang G; Smeltzer M; Cancio MI; Wang WC; Anghelescu DL
    Clin Trials; 2016 Aug; 13(4):409-16. PubMed ID: 27000103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tramadol infusion for the pain management in sickle cell disease: a case report.
    Erhan E; Inal MT; Aydinok Y; Balkan C; Yegul I
    Paediatr Anaesth; 2007 Jan; 17(1):84-6. PubMed ID: 17184440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
    Palm N; Floroff C; Hassig TB; Boylan A; Kanter J
    J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postoperative morphine consumption in children with sickle-cell disease.
    Crawford MW; Galton S; Naser B
    Paediatr Anaesth; 2006 Feb; 16(2):152-7. PubMed ID: 16430411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
    Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Body Mass Index and the Association With Vaso-occlusive Crises in Pediatric Sickle Cell Disease.
    Zivot A; Apollonsky N; Gracely E; Raybagkar D
    J Pediatr Hematol Oncol; 2017 May; 39(4):314-317. PubMed ID: 28221266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of opioid use in sickle cell disease.
    Han J; Saraf SL; Zhang X; Gowhari M; Molokie RE; Hassan J; Alhandalous C; Jain S; Younge J; Abbasi T; Machado RF; Gordeuk VR
    Am J Hematol; 2016 Nov; 91(11):1102-1106. PubMed ID: 27466799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pain management in adults with sickle cell disease in a medical center emergency department.
    Solomon LR
    J Natl Med Assoc; 2010 Nov; 102(11):1025-32. PubMed ID: 21141290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of intramuscular analgesic activity of butorphanol and morphine in patients with sickle cell disease.
    Gonzalez ER; Ornato JP; Ware D; Bull D; Evens RP
    Ann Emerg Med; 1988 Aug; 17(8):788-91. PubMed ID: 3394980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-Controlled Analgesia vs Intravenous Push Hydromorphone for Pain Management of Vaso-Occlusive Crisis Associated With Sickle Cell Disease.
    Russo K; Chhunchha P
    J Pain Palliat Care Pharmacother; 2023 Jun; 37(2):116-122. PubMed ID: 36701332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
    Hoppe CC; Styles L; Heath LE; Zhou C; Jakubowski JA; Winters KJ; Brown PB; Rees DC; Heeney MM
    Pediatr Blood Cancer; 2016 Feb; 63(2):299-305. PubMed ID: 26402148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Mixed-Methods Study of Pain-related Quality of Life in Sickle Cell Vaso-Occlusive Crises.
    Lin RJ; Evans AT; Wakeman K; Unterbrink M
    Hemoglobin; 2015; 39(5):305-9. PubMed ID: 26114739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of early analgesia on hospitalization outcomes for sickle cell pain crisis.
    Payne J; Aban I; Hilliard LM; Madison J; Bemrich-Stolz C; Howard TH; Brandow A; Waite E; Lebensburger JD
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27420. PubMed ID: 30151977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythrocyte cAMP in Determining Frequency of Acute Pain Episodes in Sickle Cell Disease Patients from Odisha State, India.
    Jit BP; Mohanty PK; Pradhan A; Purohit P; Das K; Patel S; Meher S; Sinha S; Mohanty JR; Behera RK; Das P
    Hemoglobin; 2019 Mar; 43(2):88-94. PubMed ID: 31290363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.